| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Mar-21 | 1,278.20 | 142.60 | 22.10p | 14.3 | 1.4 | +10% | 11.30p | 3.6% |
| 31-Mar-22 | 1,320.40 | 125.90 | 20.60p | 14.8 | n/a | -7% | 7.30p | 2.4% |
| 31-Mar-23 | 1,580.70 | 192.00 | 26.50p | 12.3 | 0.4 | +29% | 7.70p | 2.4% |
| 31-Mar-24 | 1,912.10 | 182.70 | 29.40p | 12.4 | 1.1 | +11% | 8.25p | 2.3% |
| 31-Mar-25 | 1,931.60 | (106.30) | 26.10p | 14.8 | n/a | -11% | 8.85p | 2.3% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Mar-26 | 1,976.31 | 230.64 | 30.78p | 15.6 | 0.9 | +18% | 9.54p | 0.0% |
| 31-Mar-27 | 2,101.28 | 251.50 | 34.81p | 13.8 | 1.1 | +13% | 10.40p | 0.0% |
| 31-Mar-28 | 2,233.39 | 266.06 | 38.27p | 12.5 | 1.3 | +10% | 11.18p | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
| 5 Yr High | 5 Yr Low | 5 Yr Avg | Curr / Avg | |
|---|---|---|---|---|
| Latest | 14.30 | 12.26 | 13.71 | 1.34 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
| Currency | UK Pounds |
| Share Price | 479.40p |
| Change Today | 1.00p |
| % Change | 0.21 % |
| 52 Week High | 572.00p |
| 52 Week Low | 361.00p |
| Volume | 1,587,027 |
| Shares Issued | 536.53m |
| Market Cap | £2,572.11m |
| Beta | 0.71 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 4 |
| Buy | 1 |
| Neutral | 3 |
| Sell | 2 |
| Strong Sell | 0 |
| Total | 10 |

| Latest | Previous | |
|---|---|---|
| Final | Interim | |
| Ex-Div | 24-Jul-25 | 08-Jan-25 |
| Paid | 21-Aug-25 | 07-Feb-25 |
| Amount | 6.05p | 2.80p |
| Time | Volume / Share Price |
| 16:35 | 1,140 @ 479.40p |
| 16:35 | 842,958 @ 479.40p |
| 16:35 | 453 @ 479.40p |
| 16:35 | 369 @ 479.40p |
| 16:35 | 546 @ 479.40p |
| CEO | Steve Wadey |
| Chair | Neil A Johnson |
| CFO | Martin Cooper |
You are here: research